MarketInOut Stock Screener Log In | Sign Up
 

Starling Oncology Inc

NASDAQ • Healthcare • Medical Care Facilities • Quote as of 10/23/2026
Starling Oncology Inc stock price and volume chart

Company Profile

IndustryMedical Care Facilities
SectorHealthcare
ExchangeNASDAQ
Market Capitalization693.03 mln
Float63.57 mln
Earnings Date11/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.35
Reliable

1-Year Forecast

9.40
Exceptional upside

Relative Strength

76 / 100
Strongly outperforming

Pre-Tax Margin

-6%
Marginally loss-making

ROE

210
Extraordinary

Business Description

Starling Oncology Inc., headquartered in Cerritos, California, is a cancer care company founded in 2007 that serves adult and senior patients across the United States. The company runs community clinics and infusion suites where patients can receive treatment, access specialty medications through in-office or mail-order dispensing, and take part in clinical trials. Beyond direct medical care, Starling Oncology also provides counseling, support groups, educational programs, and around-the-clock patient assistance to help people navigate their cancer journey.

Key Fundamentals

EPS-0.29
ROE210
RPS5.81
ROIC-30.34
ROA-21.54
Interest Cover-3.42
EBITDA, mln-21.85
EV / EBITDA-33.30
EV / EBIT-25.39
Revenue, mln587
EV / Revenue1.24

Quote Details

Last 6.71
Change -0.2 (-2.89%)
Open 6.92
Volume 1,055,449
Turnover 7,082,063
Average Volume 1,147,822

Financial Ratios

Pre-Tax Profit Margin-6
Current Ratio1.36
Price / Cash Flow2,134
Price / Sales1.13

Financial Strength

Altman Z-Score2.69
Piotroski F-Score 5 / 9
Beneish M-Score-3.35
1-Year Target Price9.40
Short Ratio5.23
Short % of Float7.58

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.35% 87 / 100   
1 Month 3.07% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog